Advanced search
Publication Cover
Renal Failure Volume 34, 2012 - Issue 6
Submit an article Journal homepage
435
Views
2
CrossRef citations to date
0
Altmetric
Clinical Study

Roles of Human Urotensin II in Volume Resistance Hypertension in Peritoneal Dialysis Patients

Qiong BaiDepartment of Nephrology, Peking University Third Hospital, Beijing, PR China
,
Jing ZhangDepartment of Nephrology, Peking University Third Hospital, Beijing, PR China
,
Ai-Hua ZhangDepartment of Nephrology, Peking University Third Hospital, Beijing, PR ChinaCorrespondence[email protected] (A-HZ) or [email protected] (L-TC)
,
Li-Tao ChengDepartment of Nephrology, Peking University Third Hospital, Beijing, PR China
,
Lian HeDepartment of Nephrology, Peking University Third Hospital, Beijing, PR China
,
Min-Hua FanDepartment of Nephrology, Peking University Third Hospital, Beijing, PR China
,
Ya-Jun LuoDepartment of Nephrology, Peking University Third Hospital, Beijing, PR China
&
Tao WangDepartment of Nephrology, Peking University Third Hospital, Beijing, PR China
 show all
Pages 713-717 | Received 04 Jan 2012, Accepted 28 Feb 2012, Published online: 02 Apr 2012

REFERENCES

  • Leypoldt JK, Cheung AK, Delmez JA, . Relationship between volume status and blood pressure during chronic hemodialysis. Kidney Int. 2002;61:266–275.
  • Cheng LT, Tian JP, Tang LJ, . Why is there significant overlap in volume status between hypertensive and normotensive patients on dialysis? Am J Nephrol. 2008;28:508–516.
  • Douglas SA, Ohlstein EH. Human urotensin-II, the most potent mammalian vasoconstrictor identified to date, as a therapeutic target for the management of cardiovascular disease. Trends Cardiovasc Med. 2000;10:229–237.
  • Zhang AY, Chen YF, Zhang DX, . Urotensin II is a nitric oxide-dependent vasodilator and natriuretic peptide in the rat kidney. Am J Physiol Renal Physiol. 2003;285:792–798.
  • O’Brien E, Mee F, Atkins N. Validation of three devices for home blood pressure measurement. Am J Hypertens. 1995;8:22A. Abstract.
  • Jabary NS, Herrero AM, Gonzalez JA. The use of antihypertensive therapy in Spain (1986–1994). Am J Hypertens. 2000;13:607–610.
  • Blake PG, Bargman JM, Brimble KS, . Clinical practice guidelines and recommendations on peritoneal dialysis adequacy 2011. Perit Dial Int. 2011;31(2):218–239.
  • Chamney PW, Wabel P, Moissl UM, . A whole-body model to distinguish excess fluid from the hydration of major body tissues. Am J Clin Nutr. 2007;85:80–89.
  • Moissl U, Bosaeus I, Lemmey A, . Validation of a 3C model for determination of body fat mass. J Am Soc Nephrol. 2007;18A:257.
  • Luo YJ, Wang T. What is the upper limitation of volume in Chinese peritoneal dialysis patients? Blood Purif. 2011;31:289–295.
  • Cheung BM, Leung R, Man YB, . Plasma concentration of urotensin II is raised in hypertension. Hypertension. 2004;22:1341–1344.
  • Nolph KD, Moore HL, Prowant B, . Cross-sectional assessment of weekly urea and creatinine clearances and indices of nutrition in continuous ambulatory peritoneal dialysis patients. Perit Dial Int. 1999;13:178–183.
  • Watson P, Watson I, Batt R. Total body water volumes for adult males and females estimated from simple anthropometric measurements. Am J Clin Nutr. 1980;33:27–39.
  • Watanabe T, Suguro T, Kanome T, . Human urotensin II accelerates foam cell formation in human monocyte-derived macrophages. Hypertension. 2005;46:738–744.
  • Totsune K, Takahashi K, Arihara Z, . Increased plasma urotensin-II levels in patients with diabetes mellitus. Clin Sci (Lond). 2003;104:1–5.
  • Rossowski WJ, Cheng BL, Taylor JE, . Human urotensin II-induced aorta ring contractions are mediated by protein kinase C, tyrosine kinase a and Rho kinase: Inhibition by somatostatin receptor agonists. Eur J Pharmacol. 2002;438:159–170.
  • Gendron G, Gobeil Jr. F, Belanger S, . Urotensin II-induced hypotensive responses in Wistar-Kyoto (Wky) and spontaneously hypertensive (Shr) rats. Peptides. 2005;26:1468–1474.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.